04:31 PM EST, 02/28/2025 (MT Newswires) -- David Altshuler, Executive Vice President, Chief Scientific Officer, on February 26, 2025, sold 1,272 shares in Vertex Pharmaceuticals ( VRTX ) for $610,560. Following the Form 4 filing with the SEC, Altshuler has control over a total of 32,974 common shares of the company, with 32,974 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532025000120/xslF345X05/wk-form4_1740777806.xml